Global investors are looking to buy up US
equities as they predict a year of low growth and low inflation in
2012, BofA Merrill Lynch’s monthly survey of fund managers has
found.

Almost two-thirds of the 190 institutional
investors that took part in the December survey said that 2012 will
be a year of below-trend growth and below-trend inflation.

Investors displayed a preference for US and
emerging market equities, while 72% of the panel said the Eurozone
had the least favourable outlook for corporate profits.

 

Parallels with peers

Several private banks have made similar predictions in their
2012 investment outlook research (see PBI 279). UBS Wealth
Management recommended avoiding Eurozone equities in favour of ones
from the US, UK and emerging markets, in their 2012 investment
outlook.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Deutsche Bank Private Wealth Management have
also backed US equities to perform next year, while Barclays
Wealth gave an overweight  rating to developed
equities and remained neutral on emerging markets.

 

Shoring up defences

Merrill Lynch’s December survey said that
investors have been consolidating defensive positioning in
equities, with global allocations to pharmaceuticals and staples
increasing in the past month.

In contrast, investors have reduced exposure
to growth and cyclical sectors such as technology, industrials and
discretionary.

UBS said that for the next year they too
prefer defensive sectors like consumer staples and healthcare.